Date: Oct 04, 2022 Source: Company Data (
click here to go to the source)
[October4, 2022 -- Minneapolis, MN] The National Institute of Health -- National Heart Lung and Blood Institute (NIH-NHLBI) has selected AdvancedCPR Solutions® to present at its Company Showcase during the American Heart Association's annual Scientific Sessions meeting. Dr. Keith Lurie, world-renown cardiologist, innovator and Founder and Chief Medical Officer of AdvancedCPR Solutions®, will present information on the company and the latest science surrounding Neuroprotective CPR as part of the showcase on November 6.
The NIH-NHLBI Company Showcase will feature six companies who have received funds from the NHLBI and are advancing innovation in resuscitation sciences.
The Company Showcase will occur on Sunday, November 6 from 3:30 to 5 p.m.
About Neuroprotective Head Up CPR:
Neuroprotective Head Up CPR, known commercially as the ElevatedCPR® method, is a broad, patent-protected and technologically advanced technique for performing device-assisted head up CPR that incorporates raising the head, heart, and thorax in a multi-level elevation, in a controlled sequence, in conjunction with the best practice bundle of care including use of high quality or mechanical CPR and an impedance threshold device.
AdvancedCPR Solutions' initial product -- the EleGARD™ Patient Positioning System -- is the only device that precisely and consistently elevates a patient's head and thorax from supine to multi-level positioning in a controlled sequential manner to support the practice of the ElevatedCPR method in both pre-hospital and hospital settings.
Founded in Minneapolis, Minnesota in 2015 by an experienced team that previously developed multiple novel resuscitation technologies currently in widespread clinical practice, AdvancedCPR Solutions is a commercialization-stage medical device firm focused on the development and market adoption of delivery mechanisms, methods and devices that support the practice of the ElevatedCPR method to potentially improve survival of cardiac arrest.
